Literature DB >> 6689960

Agranulocytosis associated with semisynthetic penicillins and cephalosporins. Report of 7 cases.

L Schmid, W Heit, R Flury.   

Abstract

Within one year we observed in the same intensive care unit seven severely polytraumatized patients with agranulocytosis (AG) associated with treatment by semisynthetic penicillins or cephalosporins combined with aminoglycosides. Antibiotics were given because of severe bacterial respiratory or generalised infections. Five patients died, four of them without haematological remission. Bone marrow aspirates showed hypoplasia of granulopoiesis due to a lack of mature cells. Leukocyte and granulocyte counts in the blood declined continuously over a period of 8 to 11 days. In average, minimal granulocyte counts occurred after 21 days of hospitalisation and 14 days of antibiotic drug exposure. Beside the incriminated antibiotics all patients were treated sporadically with other agents of which may cause AG. Granulocyte kinetics and serial bone marrow examinations of one patient suggest a phenothiazine type of AG, which is caused by a toxic damage of granulopoiesis. Declining absolute granulocyte counts in the blood together with persisting high temperatures during antibiotic treatment should give rise to the suspicion of a beginning AG.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6689960     DOI: 10.1007/bf00320712

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  28 in total

1.  Letter: Cephalothin-induced granulocytopenia.

Authors:  M A DiCato; L Ellman
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

2.  Neutropenia probably resulting from nafcillin.

Authors:  M Sandberg; C U Tuazon; J N Sheagren
Journal:  JAMA       Date:  1975-06-16       Impact factor: 56.272

3.  [Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins].

Authors:  S MOESCHLIN; K WAGNER
Journal:  Acta Haematol       Date:  1952 Jul-Aug       Impact factor: 2.195

4.  Studies on agranulocytosis. IV. Effects of chlorpromazine on nucleic acid synthesis of bone marrow cells in vitro.

Authors:  A V PISCIOTTA; J KALDAHL
Journal:  Blood       Date:  1962-09       Impact factor: 22.113

5.  Profound neutropenia caused by oxacillin.

Authors:  D W Ortbals; J J Marr
Journal:  South Med J       Date:  1977-10       Impact factor: 0.954

6.  [Reversible allergic agranulocytosis due to ampicillin therapy].

Authors:  W Stille
Journal:  Med Welt       Date:  1969-09-06

7.  Neutropenia after penicillins: toxic or immune-mediated?

Authors:  K A Neftel; M Wälti; H Spengler; A von Felten; S A Weitzman; H Bürgi; A L de Weck
Journal:  Klin Wochenschr       Date:  1981-08-17

8.  Oxacillin-induced granulocytopenia.

Authors:  J A Fallon; A R Tall; M G Janis; M J Brauer
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

9.  [Neutropenia as side effect of azlocillin in an infant (author's transl)].

Authors:  G Hofmann; H Saule
Journal:  Klin Padiatr       Date:  1978-07       Impact factor: 1.349

10.  Nafcillin-induced neutropenia in children.

Authors:  G R Greene; E Cohen
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

View more
  4 in total

Review 1.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Transient pancytopenia. A report from the International Agranulocytosis and Aplastic Study.

Authors:  M Keisu; W Heit; G Lambertenghi-Deliliers; J Parcells-Kelly; A Polliack; H Heimpel
Journal:  Blut       Date:  1990-10

Review 3.  Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

Authors:  S R Norrby
Journal:  Med Toxicol       Date:  1986 Jan-Feb

4.  Intestinal microbiota modulation and improved growth in pigs with post-weaning antibiotic and ZnO supplementation but only subtle microbiota effects with Bacillus altitudinis.

Authors:  Daniel Crespo-Piazuelo; Peadar G Lawlor; Samir Ranjitkar; Paul Cormican; Carmen Villodre; Meike A Bouwhuis; Alan Marsh; Fiona Crispie; Ruth Rattigan; Gillian E Gardiner
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.